T1	Lab_value_phrase 279 317	Initial blood pressure was 100/60 mmHg
T2	Lab_value 306 317	100/60 mmHg
T3	Diagnostic_procedure 287 301	blood pressure
T4	Lab_value_phrase 319 336	pulse rate 70/min
T5	Lab_value 330 336	70/min
T6	Diagnostic_procedure 319 329	pulse rate
T7	Lab_value_phrase 338 361	respiration rate 20/min
T8	Lab_value 355 361	20/min
T9	Diagnostic_procedure 338 354	respiration rate
T10	Lab_value_phrase 387 455	The laboratory findings were white blood cell 12,000/mm3 (poly: 70%)
T11	Lab_value 433 443	12,000/mm3
T12	Diagnostic_procedure 416 432	white blood cell
T13	Lab_value_phrase 457 477	hemoglobin 12.8 g/dL
T14	Lab_value 468 477	12.8 g/dL
T15	Diagnostic_procedure 457 467	hemoglobin
T16	Lab_value_phrase 479 499	platelet 198,000/mm3
T17	Lab_value 488 499	198,000/mm3
T18	Diagnostic_procedure 479 487	platelet
T19	Lab_value_phrase 569 603	aspartate aminotransferase 22 IU/L
T20	Lab_value 596 603	22 IU/L
T21	Diagnostic_procedure 569 595	aspartate aminotransferase
T22	Lab_value_phrase 605 637	alanine aminotransferase 12 IU/L
T23	Lab_value 630 637	12 IU/L
T24	Diagnostic_procedure 605 629	alanine aminotransferase
T25	Lab_value_phrase 639 664	total bilirubin 0.5 mg/dL
T26	Lab_value 655 664	0.5 mg/dL
T27	Diagnostic_procedure 645 654	bilirubin
T28	Lab_value_phrase 666 695	alkaline phosphatase 134 IU/L
T29	Lab_value 687 695	134 IU/L
T30	Diagnostic_procedure 666 686	alkaline phosphatase
T31	Lab_value_phrase 697 727	lactate dehydrogenase 295 IU/L
T32	Lab_value 719 727	295 IU/L
T33	Diagnostic_procedure 697 718	lactate dehydrogenase
T34	Lab_value_phrase 729 766	gamma-glutamyl transpeptidase 26 IU/L
T35	Lab_value 759 766	26 IU/L
T36	Diagnostic_procedure 744 758	transpeptidase
T37	Lab_value_phrase 768 796	protein/albumin 6.4/4.0 g/dL
T38	Lab_value 784 796	6.4/4.0 g/dL
T39	Diagnostic_procedure 768 783	protein/albumin
T40	Lab_value_phrase 798 817	uric acid 5.0 mg/dL
T41	Lab_value 808 817	5.0 mg/dL
T42	Diagnostic_procedure 798 807	uric acid
T43	Lab_value_phrase 819 865	blood urea nitrogen/creatinine 16.6/0.7 mg/dL.
T44	Lab_value 850 864	16.6/0.7 mg/dL
T45	Diagnostic_procedure 819 849	blood urea nitrogen/creatinine
T46	Lab_value_phrase 959 976	HBV-DNA <20 IU/mL
T47	Lab_value 968 976	20 IU/mL
T48	Diagnostic_procedure 959 966	HBV-DNA
T49	Lab_value_phrase 1009 1064	The patient's serum α-fetoprotein (AFP) was 676.5 ng/mL
T50	Lab_value 1053 1064	676.5 ng/mL
T51	Diagnostic_procedure 1029 1042	α-fetoprotein
T52	Lab_value_phrase 1069 1114	carbohydrate antigen 19-9 (CA19-9) <0.6 U/mL.
T53	Lab_value 1105 1113	0.6 U/mL
T54	Diagnostic_procedure 1069 1089	carbohydrate antigen
T55	Lab_value_phrase 1146 1236	which showed a 9 cm sized necrotic mass with internal hemorrhage at the right hepatic lobe
T56	Lab_value 1161 1165	9 cm
T57	Diagnostic_procedure 1181 1185	mass
T58	Lab_value_phrase 1457 1520	The serum AFP was decreased to 7.67 ng/mL at time of discharge.
T59	Lab_value 1488 1498	7.67 ng/mL
T60	Diagnostic_procedure 1461 1470	serum AFP
T61	Lab_value_phrase 1653 1792	follow-up abdominal CT scanning showed previously unseen a 5.5 cm sized left subphrenic mass with mild enhancement in delayed image (Fig.3A
T62	Lab_value 1712 1718	5.5 cm
T63	Diagnostic_procedure 1741 1745	mass
T64	Lab_value_phrase 1801 1835	AFP was increased to 312.06 ng/mL.
T65	Lab_value 1822 1834	312.06 ng/mL
T66	Diagnostic_procedure 1801 1804	AFP
T67	Lab_value_phrase 2954 3101	Follow-up abdominal CT scan performed 1 month after reoperation showed a newly onset 1.7 cm sized subtle enhancing soft tissue mass in splenic bed,
T68	Lab_value 3039 3045	1.7 cm
T69	Diagnostic_procedure 3081 3085	mass
T70	Lab_value_phrase 3298 3329	Follow-up AFP was 162.69 ng/mL.
T71	Lab_value 3316 3328	162.69 ng/mL
T72	Diagnostic_procedure 3308 3311	AFP
T73	Lab_value_phrase 3330 3385	Systemic chemotherapy started with cisplatin (60 mg/m2)
T74	Lab_value 3376 3384	60 mg/m2
T75	Diagnostic_procedure 3365 3374	cisplatin
T76	Lab_value_phrase 3387 3420	5-fluorourasil (5-FU) (600 mg/m2)
T77	Lab_value 3410 3419	600 mg/m2
T78	Diagnostic_procedure 3403 3407	5-FU
T79	Lab_value_phrase 3422 3445	vincristine (1.5 mg/m2)
T80	Lab_value 3435 3444	1.5 mg/m2
T81	Diagnostic_procedure 3422 3433	vincristine
T82	Lab_value_phrase 3505 3567	Entecavir 0.5 mg was also started for chemoprophylaxis of CHB.
T83	Lab_value 3515 3521	0.5 mg
T84	Diagnostic_procedure 3543 3559	chemoprophylaxis
T85	Lab_value_phrase 3755 3804	follow-up AFP was further increased to 254 ng/mL.
T86	Lab_value 3794 3803	254 ng/mL
T87	Diagnostic_procedure 3765 3768	AFP
T88	Lab_value_phrase 3805 3910	So chemotherapy regimen was changed to carboplatin (350 mg/m2) with doxorubicin (30 mg/m2) every 3 weeks.
T89	Lab_value 3857 3866	350 mg/m2
T90	Diagnostic_procedure 3873 3884	doxorubicin
T91	Lab_value_phrase 4116 4157	follow-up AFP was increased 1510.19 ng/mL
T92	Lab_value 4144 4157	1510.19 ng/mL
T93	Diagnostic_procedure 4126 4129	AFP
T94	Lab_value_phrase 4561 4602	showed white blood cell 310/mm3 (poly 20%
T95	Lab_value 4585 4592	310/mm3
T96	Diagnostic_procedure 4568 4584	white blood cell
T97	Lab_value_phrase 4616 4632	protein 3.6 g/dL
T98	Lab_value 4624 4632	3.6 g/dL
T99	Lab_value_phrase 4637 4680	albumin 2.3 g/dL on ascitic fluid analysis.
T100	Lab_value 4645 4653	2.3 g/dL
T101	Diagnostic_procedure 4665 4670	fluid
T102	Lab_value_phrase 4681 4711	The serum albumin was 3.1 g/dL
T103	Lab_value 4703 4711	3.1 g/dL
T104	Diagnostic_procedure 4685 4698	serum albumin
T105	Lab_value_phrase 4716 4767	serum-ascites albumin gradient (SAAG) was 0.8 g/dL.
T106	Lab_value 4758 4766	0.8 g/dL
T107	Diagnostic_procedure 4730 4737	albumin
T108	Lab_value_phrase 4830 4865	The AFP was 6881.93 ng/mL on serum.
T109	Lab_value 4842 4855	6881.93 ng/mL
T110	Diagnostic_procedure 4859 4864	serum
